Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Behavioral Neurology & Neuropsychiatry
How do you approach patients considering Leqembi therapy for Alzheimer’s disease who cannot get MRIs?
Answer from: at Community Practice
They are excluded.
Sign In
or
Register
to read more
18249
Related Questions
How does the presence of 1-3 microbleeds on MRI influence your choice of anti-amyloid therapies for patients with MCI or mild AD?
How do you decide when to order blood-based biomarker testing for Alzheimer's disease and which one to choose?
What patient factors most strongly influence your decision to start biologic agents in mild cognitive impairment?
How do you utilize FDG PET in the evaluation of dementias?
How do stroke-risk considerations affect your use of atypical antipsychotics for patients with dementia?
When do you suspect an autoimmune encephalitis in a child or adolescent with new-onset psychosis?
How do you differentiate between HIV associated neurocognitive disease (HAND) and other causes of neurocognitive impairment?
How do you counsel non-diabetic patients who wish to start metformin to reduce the risk of developing dementia?
What would be your approach to the consideration of the use of antiamyloid monoclonal antibodies for nonamnestic Alzheimer's disease with a positive biomarker for brain amyloid pathology?
What is your approach to determining eligibility for hospice in persons with Alzheimer's disease?